Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Xtant Medical Holdings, Inc.Financial_Report.xls
EX-4.2 - EXHIBIT 4.2 - Xtant Medical Holdings, Inc.v402499_ex4-2.htm
EX-31.1 - EXHIBIT 31.1 - Xtant Medical Holdings, Inc.v402499_ex31-1.htm
EX-32.1 - EXHIBIT 32.1 - Xtant Medical Holdings, Inc.v402499_ex32-1.htm
EX-10.4 - EXHIBIT 10.4 - Xtant Medical Holdings, Inc.v402499_ex10-4.htm
EX-23.1 - EXHIBIT 23.1 - Xtant Medical Holdings, Inc.v402499_ex23-1.htm
EX-31.2 - EXHIBIT 31.2 - Xtant Medical Holdings, Inc.v402499_ex31-2.htm
EX-10.9 - EXHIBIT 10.9 - Xtant Medical Holdings, Inc.v402499_ex10-9.htm
EX-10.1 - EXHIBIT 10.1 - Xtant Medical Holdings, Inc.v402499_ex10-1.htm
EX-10.10 - EXHIBIT 10.10 - Xtant Medical Holdings, Inc.v402499_ex10-10.htm
10-K - 10-K - Xtant Medical Holdings, Inc.v402499_10k.htm


Exhibit 32.2


Section 1350   Certification of Chief Financial Officer


In connection with the Annual Report on Form 10-K of Bacterin International Holdings, Inc. (the "Company") for the annual period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John P. Gandolfo, Chief Financial Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:


(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ John P. Gandolfo  
John P. Gandolfo  
Chief Financial Officer  
March 18, 2015